Persistence of DNA in cell cultures may jeopardize the analysis of human herpesvirus 6 dynamics by means of real-time PCR

Journal of Virological Methods

Volumn 125, Issue 1, 2005, Pages 95-98

  Bonnafous, Pascale ^a   Gautheret Dejean, Agnès ^a,b   Boutolleau, David ^a,c   Caïola, Delphine ^a   Agut, Henri ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

Antiviral drug; Susceptibility assay; Virus cell load; Virus growth kinetics

Indexed keywords

ANTIVIRUS AGENT; VIRUS DNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOLYSIS; DRUG SENSITIVITY; HERPES; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNOASSAY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOBLAST; VIROGENESIS; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 6;

EID: 14544295721     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.12.001     Document Type: Article

References (17)

1. D.V. Ablashi, H.B. Eastman, C.B. Owen, M.M. Roman, J. Friedman, J.B. Zabriskie, D.L. Peterson, G.R. Pearson, and J.E. Whitman Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients J. Clin. Virol. 16 2000 179 191
2. H. Agut, H. Collandre, J.T. Aubin, D. Guetard, V. Favier, D. Ingrand, L. Montagnier, and J.M. Huraux In vitro sensitivity of human herpesvirus-6 to antiviral drugs Res. Virol. 140 1989 219 228
3. A. Akesson-Johansson, J. Harmenberg, B. Wahren, and A. Linde Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl] guanine (2HM-HBG) and other antiviral compounds Antimicrob. Agents Chemother. 34 1990 2417 2419
4. E. Denes, L. Magy, K. Pradeau, S. Alain, P. Weinbreck, and S. Ranger-Rogez Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient Emerg. Infect. Dis. 10 2004 729 731
5. A. Gautheret-Dejean, C. Manichanh, F. Thien-Ah-Koon, A.M. Fillet, N. Mangeney, M. Vidaud, N. Dhedin, J.P. Vernant, and H. Agut Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients J. Virol. Meth. 100 2002 27 35
6. M.C. Long, D.J. Bidanset, S.L. Williams, N.L. Kushner, and E.R. Kern Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry Antiviral Res. 58 2003 149 157
7. M. Macé, C. Manichanh, P. Bonnafous, S. Précigout, D. Boutolleau, A. Gautheret-Dejean, and H. Agut Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antivirals Antimicrob. Agents Chemother. 47 2003 3021 3024
8. C. Manichanh, P. Grenot, A. Gautheret-Dejean, P. Debre, J.M. Huraux, and H. Agut Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis Cytometry 40 2000 135 140
9. C. Manichanh, C. Olivier-Aubron, J.P. Lagarde, J.T. Aubin, P. Bossi, A. Gautheret-Dejean, J.M. Huraux, and H. Agut Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo J. Gen. Virol. 82 2001 2767 2776
10. P.J. Nash, R.K. Avery, W.H. Tang, R.C. Starling, A.J. Taege, and M.H. Yamani Encephalitis owing to human herpesvirus-6 after cardiac transplant Am. J. Transplant. 4 2004 1200 1203
11. R.R. Razonable, A. Rivero, R.A. Brown, G.D. Hart, M.J. Espy, H. van Cruijsen, J. Wilson, C. Groettum, W. Kremers, T.F. Smith, and C.V. Paya Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection Clin. Transplant. 17 2003 114 120
12. D. Reymen, L. Naesens, J. Balzarini, A. Holy, H. Dvorakova, and E. De Clercq Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6 Antiviral Res. 28 1995 343 357
13. C. Robert, V. Massonneau, P. Pothier, A. Clement, G. Hejblum, P. Hubert, J.T. Aubin, and H. Agut Selection and characterization of two specific monoclonal antibodies directed against the two variants of human herpesvirus-6 Res. Virol. 149 1998 403 411
14. D. Safronetz, M. Petric, R. Tellier, B. Parvez, and G.A. Tipples Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase J. Med. Virol. 71 2003 434 439
15. Y. Sergerie, and G. Boivin Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR J. Clin. Microbiol. 41 2003 3897 3900
16. R. Stranska, A.M. Van Loon, M. Polman, and R. Schuurman Application of real-time PCR for determination of antiviral drug susceptibility of herpes simplex virus Antimicrob. Agents Chemother. 46 2002 2943 2947
17. K. Yamanishi, T. Okuno, K. Shiraki, M. Takahashi, T. Kondo, Y. Asano, and T. Kurata Identification of human herpesvirus-6 as a causal agent for exanthem subitum Lancet 14 1988 1065 1067